Berlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...

Recent advances in RAS-targeted therapies revolutionize treatment for gastrointestinal cancers, promising improved outcomes and new clinical strategies for oncologists.

"I thought I was too young to have cancer," told Alexis Klimpl, adding: " "In my eyes, my breasts betrayed me." ...

The U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix) in combination with rituximab and ...